Archives: Speakers

Patrick T. Moran is the founding board member of the Texas Cannabis Industry Association. Beginning October of 2013, he started to apply his professional experience to the emerging cannabis industry. He maintains Texas State Bar licensure and invested time & energy into the last three Texas legislative sessions, to help advance cannabis law reform. Mr. Moran is also founder and CEO of Pebble Global Holdings (www.pebble.life) an emerging bio-pharmaceutical company committed to natural plant solutions that include CBD-based products. Coming from a family with three generations of medical professionals on his mother’s side and six generations of industrial-scale agriculture & entrepreneurship on his father’s, he has led the company’s R&D, guided overall strategy and successful fundraising. Post Texas Hemp legalization, he is now helping advise TCIA coming into the 2020 elections and using the results of Pebble’s in-house clinical trial to inform subsequent larger scale studies.

With more than 20 years of experience in IT recycling, reselling, data security and data destruction, Damian is driven by helping companies dispose of IT securely and sustainably. He is passionate about enabling a circular economy and helping organizations achieve their ESG goals. Damian joined CSI in 2001 as a European Lifecycle Services Manager and was promoted to European Asset Remarketing & Lifecycle Services in 2019. After successfully growing the business, Damian became the European Asset Remarketing & Lifecycle Services Manager at EPC Global Solutions Europe, part of the CSI Leasing, Inc. family. Damian successfully leads EPC’s European subsidiaries in the UK, Slovakia, Germany, and Spain.

Wayne is Senior Vice President, Product for Rave Platform Technology (including Rave EDC, Rave RTSM, Rave Coder, and Rave Safety Gateway) at Medidata. His responsibilities include the strategy, development, and delivery of these products across all Research & Development disciplines. Prior to joining Medidata, Wayne spent 12 years overseeing Product Management for clinical technology used by Data Management and Biometrics at PRA Health Sciences. This involved oversight of Platform as a Service, Software as a Service, on-premise deployed environments and in-house developed solutions.

Kelli is a dynamic and skilled Clinical Trial Manager with 12 years of Pharmaceutical/CRO industry experience with extensive knowledge of clinical monitoring, trial management (regionally and globally), and trial operations from start-up to close out. Talents include exceptional leadership, organizational and analytic skills, highly adaptable to multiple demands and shifting priorities, collaborative with cross-functional teams and key stakeholders, and exhibit keen oversight of external vendors.

A qualified adviser himself, Daniel works directly with advice and investment management firms to understand their commercial challenges and explore how technology can help them to build stronger, more sustainable businesses. His team is also responsible for scanning the market for existing and emerging innovations, which, through Seccl, can help advisers to build the efficient businesses of the future.

Eszter Vass is Head of Product Enablement at CREALOGIX – a global leader in digital banking, collaborating with some of the world’s leading wealth management firms. Eszter has been in the space of digital banking for 10+ years in various roles, focusing on product innovation, execution and the evolving digital strategies of financial institutions.

Passionate clinical researcher experienced in biopharmaceutical, IVD and medical device industries. Therapeutic Areas: CNS, Infectious Diseases, Aesthetics/Dermatology, Neurovascular, ENT.

Thomas Doerge is the Global Head of Active Implantable Medical Devices at BSI and provides Medical Device expertise leadership and mentoring in areas of competence to the team. Prior to this position Thomas mentored and coached team members to deliver robust certificate decisions for Design dossier reviews as a Technical Team Manager. He has over 20 years’ experience in the Research and Development of AIMD products specifically in the field of neuromodulation.